MannKind Corp
MNKD
#5939
Rank
A$1.76 B
Marketcap
A$5.48
Share price
-0.63%
Change (1 day)
-37.53%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): A-$0.10

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is A-$0.09773. In 2025 the company made an earnings per share (EPS) of A$0.02792 a decrease over its 2024 EPS that were of A$0.14.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.10-463.57%
2025A$0.02792-80%
2024A$0.14
2022A-$0.476.25%
2021A-$0.4528%
2020A-$0.35-7.41%
2019A-$0.38
2017A-$1.55-188.1%
2016A$1.76-128.31%
2015A-$6.2174.51%
2014A-$3.56-20.31%
2013A-$4.47-32.63%
2012A-$6.63-28.03%
2011A-$9.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.83-1,971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$6.00-6,236.29%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
A$39.41-40,421.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$4.99-5,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$4.08-4,271.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$11.76 11,928.57%๐Ÿ‡บ๐Ÿ‡ธ USA